Congenital sodium diarrhoea caused by rare de novo activating guanylate cyclase mutation
Bajracharya S, Stich D, Berman J, Biank V. Congenital sodium diarrhoea caused by rare de novo activating guanylate cyclase mutation. BMJ Case Rep. 2022;15(12):e251632. Published 2022 Dec 29. doi:10.1136/bcr-2022-251632
A male infant with prenatal history significant for polyhydramnios requiring multiple amnioreductions with suspicion of small bowel atresia was born at 31 weeks 5 days' gestation with abdominal distension. He underwent three exploratory laparotomies and ileostomy for small bowel obstruction and was found to have fluid-filled intestinal dilatation. Serum and stool chemistries suggested sodium secretory diarrhoea. A rapid whole-exome sequencing confirmed de novo guanylate cyclase mutation variant as a cause for his congenital sodium secretory diarrhoea. He required large volume of fluid and electrolyte replacement along with total parenteral nutrition. Several medications to restore normal sodium homeostasis by targeting molecular mechanisms and pathogenesis described in previous literature failed to decrease stool output and electrolyte loss. He was discharged home at 11 months of age on total parenteral nutrition and weekly iron therapy.
Advocate Children's Hospital, Park Ridge